BioNTech SE BNTX
NASDAQ BNTX
$115.29 +4.40 (+3.97%)
As of: Aug 21, 2026 · 1:58 PM EDT

BioNTech SE (BNTX) EBITDA Margin (QoQ) (2018 - 2025)

BioNTech SE (BNTX) EBITDA Margin (QoQ) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.59 Bn 131.73 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.21 Bn 78.22 Bn 3.93 Bn
3 Argenx Se 65.65 Bn 60.47 Bn 1.37 Bn
4 Moderna 57.67 Bn 52.53 Bn 52.00 Mn
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 27.90 Bn 9.51 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 Roivant Sciences 26.34 Bn 26.34 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,249.00
Sep 30, 2025 18,905.00
Jun 30, 2025 10,004.00
Mar 31, 2025 -30,466.00
Dec 31, 2024 1,164.00
Sep 30, 2024 75,158.00
Jun 30, 2024 -48,038.00
Mar 31, 2024 -30,594.00
Dec 31, 2023 2,741.00
Sep 30, 2023 34,406.00
Jun 30, 2023 -38,714.00
Mar 31, 2023 -2,572.00
Dec 31, 2022 -1,523.00
Sep 30, 2022 -5,649.00
Jun 30, 2022 6,308.00
Mar 31, 2022 66.00
Dec 31, 2021 735.00
Sep 30, 2021 -149.00
Jun 30, 2021 -206.00
Sep 30, 2020 8,243.00